GLP-1 clinical practice

Semaglutide Full Journey

Complete semaglutide weight-loss journey: 20-week Ozempic titration (0.25mg → 2.4mg) followed by Wegovy maintenance. Covers the standard FDA-label titration schedule used in clinical practice.

Duration

—

Steps

5

Total Weeks

12

Route

SubQ

Protocols

2

Source

clinical practice

Protocol Timeline

Step Weeks Dose Compound Note
1 4 0.25 mg Semaglutide (Injectable) Initiation dose — for GI tolerability, not therapeutic
2 4 0.5 mg Semaglutide (Injectable) First therapeutic dose
3 4 1 mg Semaglutide (Injectable) Standard target dose — increase if additional glycemic control needed
4 0 2 mg Semaglutide (Injectable) Maximum dose — maintenance
1 0 2.4 mg Semaglutide (Injectable) Target maintenance dose for weight management

Rationale

GI side effects are most common in the first 4–8 weeks. Titrate only when tolerating current dose well. Do not rush the escalation.

Compounds Used

Semaglutide (Injectable)

semaglutide_subq · primary

→

Related Tools

Medication Level Plotter

Simulate blood levels for this regimen

Dose Calculator

Calculate reconstitution and draw volumes

Split Dose Calculator

Divide weekly totals into multiple injections

Track this regimen in Doseline

Adopt Semaglutide Full Journey as a template, set reminders for every step, and log doses as you go. All free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.